Location History:
- Suwon-si, KR (2004)
- Yongin-si, KR (2020)
Company Filing History:
2 out of 16 
2 out of 260 
1 out of 131,214 
Years Active: 2004-2025
Title: Innovations of Jae Chan Park
Introduction
Jae Chan Park is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of biomedical research, particularly in the development of innovative therapeutic agents for cancer treatment. With a total of three patents to his name, his work focuses on bispecific antibodies that target specific cancer markers.
Latest Patents
One of Jae Chan Park's latest patents is a bispecific antibody specifically binding to GPNMB and CD3. This antibody demonstrates high affinity and specificity to both CD3 (cluster of differentiation 3) and GPNMB (glycoprotein non-metastatic melanoma protein B). The invention reveals that this bispecific antibody can induce the death of cancer cells expressing GPNMB while inhibiting their proliferation. Therefore, it holds promise as an effective therapeutic agent for cancers that express GPNMB. Another significant patent is related to an anti-mesothelin antibody and its composition. This invention includes an antibody specifically bound to mesothelin (MSLN), along with a nucleic acid encoding the antibody, a vector, and a host cell. The antibody has high affinity and specificity to the antigen, making it a valuable tool for the treatment or diagnosis of cancer or tumor diseases.
Career Highlights
Jae Chan Park has worked with reputable organizations in the biomedical field. He has been associated with the Mogam Institute for Biomedical Research, where he contributed to various research projects. Additionally, he has worked with The Green Cross Corporation, further enhancing his expertise in the development of therapeutic antibodies.
Collaborations
Throughout his career, Jae Chan Park has collaborated with several professionals in the field. Notable coworkers include Eun Jung Song and Deck Gyu Park, who have contributed to his research endeavors.
Conclusion
Jae Chan Park's innovative work in the development of bispecific antibodies showcases his commitment to advancing cancer treatment. His patents reflect significant advancements in targeted therapies, which could lead to improved outcomes for patients suffering from cancer.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.